May 5, 2021

Xcenda's Allen Lising sits down with The Center for Biosimilars to discuss biosimilar pipeline information

Speaking with AJMC, Xcenda's Allen Lising, managing director of FormularyDecisions, explains how stakeholders are using pre-approval information to make business decisions. He also discussed the Biosimilars Hub within FormularyDecisions, as well as the launch of ICER Analytics, a cloud-based platform that's revolutionizing how payers, pharma, and patient groups develop formularies, negotiate drug prices, and explore new ways to apply evidence equitably.
screenshot of Allen Lising video call

AMJC | The Center for Biosimilars® 

Xcenda's Allen Lising discusses the growing emphasis on biosimilar pipeline information